NCT00180687View on ClinicalTrials.gov

Clinical Trial of the Use of Intraperitoneal Local Anaesthetic

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Pain, Postoperative
Interventions
DRUG

Nebulised Bupivacaine intraperitoneally

Nebulised Marcaine (Bupivacaine)

DRUG

Normal Saline

Nebulised Normal Saline

DRUG

Injected Bupivacaine intraperitoneally

Injected Marcaine directly into the peritoneal cavity

OTHER

No Intraperitoneal Therapeutics

No Intraperitoneal Therapeutics given

Trial Locations (1)

W2 1NY

St. Mary's Hospital, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT00180687 - Clinical Trial of the Use of Intraperitoneal Local Anaesthetic | Biotech Hunter | Biotech Hunter